Showing results (741-750 of 1,264) with videos related to
Sort By:
Pageof 127
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|November 20, 2002
Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiencyKarl S Lang, Benjamin Roll, Svetlana Myssina, et al.The Journal of Investigative Dermatology|June 16, 2001
HLA-A2 restricted, melanocyte-specific CD8(+) T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1K S Lang, C C Caroli, A Muhm, et al.BMC Emergency Medicine|November 30, 2017
The effectiveness of prehospital hypertonic saline for hypotensive trauma patients: a systematic review and meta-analysisI E Blanchard, A Ahmad, K L Tang, et al.Nature Structural & Molecular Biology|March 2, 2023
Direct visualization of transcription-replication conflicts reveals post-replicative DNA:RNA hybridsHenriette Stoy, Katharina Zwicky, Danina Kuster, et al.Annales De Cardiologie Et D'Angeiologie|January 8, 2011
[Focus on managing AF and preventing stroke]S Ederhy, G Dufaitre, C Meuleman, et al.Journal of Medical Entomology|January 11, 2017
The Seasonal Timing of Snowshoe Hare Virus Transmission on the Island of Newfoundland, CanadaP Kate Carson, Kimberly Holloway, Kristina Dimitrova, et al.Prehospital Emergency Care|December 20, 2021
Evidence-Based Guidelines for Prehospital Pain Management: Literature and MethodsJonathan R Powell, Lorin R Browne, Kyle Guild, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 2005
Requirement for neutralizing antibodies to control bone marrow transplantation-associated persistent viral infection and to reduce immunopathologyKarl S Lang, Mike Recher, Alexander A Navarini, et al.Cell|August 13, 2017
Replication-Transcription Conflicts Generate R-Loops that Orchestrate Bacterial Stress Survival and PathogenesisKevin S Lang, Ashley N Hall, Christopher N Merrikh, et al.Human Gene Therapy|February 18, 1999
Gene therapy--phase I trial for primary untreated head and neck squamous cell cancer (HNSCC) UICC stage II-IV with a single intratumoral injection of hIL-2 plasmids formulated in DOTMA/CholB Wollenberg, Kastenbauer, H Mundl, et al.Pageof 127